Regional chemotherapeutic perfusion and infusion of brain and face tumors.
D000230:Adenocarcinoma / Q000188:drug therapy; D000564:Ameloblastoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005029:Ethylenediamines / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000188:drug therapy*; D005354:Fibrosarcoma / Q000188:drug therapy; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D007263:Infusions, Parenteral; D008466:Mechlorethamine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use*; D008579:Meningioma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use*; D012516:Osteosarcoma / Q000188:drug therapy; D010477:Perfusion; D011809:Quinones / Q000627:therapeutic use*; D012175:Retinoblastoma / Q000188:drug therapy; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D005029:Ethylenediamines; D011809:Quinones; D008466:Mechlorethamine; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan; D008727:Methotrexate